Fuld & Co. Survey Finds the C-Suite Investing in Vital Intelligence Capabilities

The pharma and biotech sector accounts for more than a quarter (27%) of all intelligence spend – amounting to over $2 million per year - the largest of any industry.

A survey conducted by Fuld & Company, examining budgets and personnel in the competitive intelligence function worldwide, shows that overall budgets are increasing for this capability. Competitive Intelligence (CI) tracks and analyses the competition so that meaningful information is provided to management to make strategic decisions about how to deal with opportunities and threats.